
Eric Mullins MD
Pediatric Anemia and Red Blood Cell Hematology, Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology
Professor of Pediatrics, University of Cincinnati College of Medicine, Research Director, Hemophilia Treatment Center, Cincinnati Children's Hospital Medical Center
Join to View Full Profile
3333 Burnet AvenueMLC 7015Cincinnati, OH 45229
Phone+1 513-517-2234
Fax+1 513-803-5095
Dr. Mullins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2004 - 2007
- Vanderbilt University Medical CenterResidency, Pediatrics, 2001 - 2004
- University of Missouri-Columbia School of MedicineClass of 2001
- University of MissouriB.S., Biochemistry, Summa Cum Laude/Honors Scholar, 1993 - 1997
Certifications & Licensure
- KY State Medical License 2021 - 2026
- OH State Medical License 2004 - 2026
- IN State Medical License 2021 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Young Investigator Award International Society on Thrombosis and Haemostasis, 2009
- Clinical Fellowship National Hemophilia Foundation, 2005
- Elected to Alpha Omega Alpha 2000
- Join now to see all
Clinical Trials
- A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura Start of enrollment: 2021 Apr 14
- A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP) Start of enrollment: 2017 Oct 13
Roles: Principal Investigator
- A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) Start of enrollment: 2017 Nov 06
Roles: Principal Investigator
Publications & Presentations
PubMed
- Hemostatic derangements associated with cardiopulmonary bypass predict outcomes in pediatric patients undergoing corrective heart surgery.Kevin Todd, Spencer J Hogue, James S Tweddell, James A Reagor, Eric Mullins
Journal of Thrombosis and Haemostasis. 2025-02-01 - Hemoglobin concentration and body mass index are determinants of plasma von Willebrand factor and factor VIII levels.Maria Carter-Febres, Matthew Fenchel, Jennifer Pomales, Cristina Tarango, Eric S Mullins
Thrombosis Research. 2024-08-01 - 1 citationsThrombotic risk associated with gender-affirming hormone therapy.Tanya L Kowalczyk Mullins, Eric S Mullins
Journal of Thrombosis and Haemostasis. 2024-08-01
Journal Articles
- Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cellsThornton S, Raghu H, Cruz C, Frederick MD, Palumbo JS, Mullins ES, Almholt K, Usher PA, and Matthew J. Flick, Blood Advances, 1/1/2017
- Blood compatibility of heparin-inspired, lactose containing, polyureas depends on the chemistry of the polymer backboneHuang Y, Shaw MA, Warmin MR, Mullins ES, and Ayres N, Polym. Chem., 1/1/2016
Books/Book Chapters
Abstracts/Posters
- Plasminogen is protective from development of neuroinflammatory paralysis via preservation of fibrin matrices.ES Mullins, GRC, Plasminogen Activation & Extracellular Proteolysis, 1/1/2016
- Thrombin and thrombin targets drives mortality and organ dysfunction in sickle cell disease.ES Mullins, FASEB SRC, Proteases in Hemostasis and Vascular Biology, 1/1/2011
- Fibrin(ogen) deficiency ameliorates the severity of transfusion related acute lung injury in mice.ES Mullins, American Society of Hematology, 1/1/2009
- Join now to see all
Lectures
- Plasmin-Mediated Fibrinolysis Enables Macrophage Migration Via Liberation from Fibrin Interactions2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Menorrhagia and Hemostasis1/1/2017
- Platelet Disorders1/1/2017
- Join now to see all
Other
- The SIPPET Trial: A Tale of Two Factors.ES Mullins, Bloodline, A Newsletter for Members of the Bleeding Disorders Community, Volume 1
1/1/2017 - A New Model for Treating Hemophilia A.ES Mullins, Bloodline, A Newsletter for Members of the Bleeding Disorders Community, Volume 2
1/1/2016 - Women and Bleeding Disorders.Mullins TK and Mullins ES, Bloodline, A Newsletter for Members of the Bleeding Disorders Community, Volume 1
1/1/2015
Professional Memberships
- Member
- Member
- International Society on Thrombosis and HaemostasisMember
- Hemostasis and Thrombosis Research SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: